Dexamethasone, Flurbiprofen Axetil and Delirium After Lung Cancer Surgery
Impact of Perioperative Dexamethasone and Flurbiprofen Axetil on Delirium After Surgery for Non-small Cell Lung Cancer: A 2x2 Factorial Randomized Controlled Trial
Sponsor: Peking University Cancer Hospital & Institute
Terminated
Protocol violation occurred frequently during the postoperative period.
Other terminated trials from Peking University Cancer Hospital & Institute
See all terminations from Peking University Cancer Hospital & Institute
Other Carcinoma, Non-Small-Cell Lung trials with similar outcome
Listed as NCT03200600, this PHASE4 trial focuses on Carcinoma, Non-Small-Cell Lung and Delirium and remains terminated or withdrawn. Sponsored by Peking University Cancer Hospital & Institute, it has been updated 9 times since 2017, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Nov 2022 — Jul 2024 [monthly]
Terminated PHASE4
-
Sep 2021 — Nov 2022 [monthly]
Terminated PHASE4
-
Jan 2021 — Sep 2021 [monthly]
Terminated PHASE4
▶ Show 4 earlier versions
-
Apr 2019 — Jan 2021 [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
-
Jun 2018 — Apr 2019 [monthly]
Recruiting PHASE4
-
Sep 2017 — Jun 2018 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jul 2017 — Sep 2017 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Peking University Cancer Hospital & Institute
- Peking University First Hospital
For direct contact, visit the study record on ClinicalTrials.gov .